Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Leishmaniasis reactivation occurs when a previously controlled or dormant leishmaniasis infection becomes active again, typically in individuals with compromised immune systems. This can happen due to conditions like HIV/AIDS, immunosuppressive treatments, or other factors that weaken the body's ability to keep the parasite in check.
This test measures IgG antibodies specific to Leishmania parasites in the blood. In individuals with a history of leishmaniasis, elevated or rising IgG antibody levels may indicate reactivation of the disease, particularly in those with immunosuppression from conditions like HIV/AIDS or treatments such as chemotherapy. This makes it a crucial monitoring tool for detecting disease recurrence.
Unlike initial leishmaniasis diagnosis which may require various methods, reactivation can be effectively monitored through blood testing. Antibody levels provide valuable insight into whether the immune system is actively responding to renewed parasite activity, making blood tests fundamental for detecting and monitoring reactivation episodes.
This testing is particularly important for individuals with a known history of leishmaniasis who are undergoing immunosuppressive therapy, have been diagnosed with HIV/AIDS, or have other conditions that compromise immune function. Regular monitoring can help detect reactivation early, allowing for prompt treatment intervention.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment, especially if you have a history of leishmaniasis and are experiencing symptoms or have risk factors for reactivation.